Our finding that GCN-2-dependent eIF2α phosphorylation protects mitochondrial protein homeostasis raises the possibility that manipulation of phospho-eIF2α status may be a therapeutic entry point for the diverse number of degenerative diseases associated with mitochondrial dysfunction [65]. This evidence concerns the gene EIF2AK4 and neurodegenerative disease.